After 5 years of follow-up of a double-blind, randomised, controlled ESCUDDO study, a single dose of either a bivalent or nonavalent HPV vaccine provided similar protection to that of two doses, which is the standard regimen for adolescents….
One dose of either a bivalent or nonavalent HPV vaccine provides protection against HPV16 or HPV18 infection and is not inferior to two doses
